Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Non-animal chondroitin sulphate in overweight subjects with knee osteoarthritis
NCT03731793Phase 4Completed
- Sponsor
- ASP Pavia
- Start
- Jan 2017
- Primary completion
- Jun 2018
- Modality
- Biomacromolecule, Polysaccharide, GAG (Glycosaminoglycan)
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of chondroitin sulfate in knee osteoarthritis (OA), sponsored by ASP Pavia. Primary endpoints: Visual Analogue Scale at 90 days and Western Ontario and McMaster Universities Arthritis Index at 90 days. Started Jan 2017; status: completed.
02
Drugs
chondroitin sulfate
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on NCT03731793.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03731793.